Related Experiment Videos
A two-year drinking-water study of dichloromethane in rodents. I. Rats
Summary
This study evaluated dichloromethane (DCM) toxicity in rats. DCM did not show carcinogenic potential, with a no-observable-effect level of 5 mg/kg/day, though some liver changes occurred at higher doses.
Area of Science:
- Toxicology
- Carcinogenesis
- Animal Studies
Background:
- Dichloromethane (DCM) is a widely used industrial solvent.
- Assessing the long-term toxicity and carcinogenic potential of DCM is crucial for human health risk assessment.
Purpose of the Study:
- To evaluate the toxicity and carcinogenic potential of dichloromethane (DCM) in Fischer 344 rats.
- To determine the no-observable-effect level (NOEL) for DCM exposure.
Main Methods:
- Administration of DCM at various doses (0-250 mg/kg/day) to rats for 104 weeks.
- Inclusion of a recovery group and interim kills at 26-week intervals for detailed analysis.
- Monitoring of body weight, consumption, hematology, serum chemistry, and histopathological examination of liver tissues.
Main Results:
- Statistically significant effects on body weight and consumption at the two highest dose levels.
- Minimal alterations in hematological and serum chemistry parameters.
- Treatment-related hepatic changes, including cellular alteration and fatty change, observed at doses above 5 mg/kg/day.
- No statistically significant increase in hepatic tumors attributable to DCM treatment was observed.
Conclusions:
- Dichloromethane (DCM) did not demonstrate carcinogenic potential under the conditions of this study.
- A no-observable-effect level (NOEL) of 5 mg/kg/day was established for DCM.
- While hepatic changes occurred at higher doses, they were not considered definitively treatment-related in the context of tumor incidence.